Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS.
Ilona B BruinsmaMarie van DijkClaire BridelTimothy van de LisdonkSanne Q HaverkortTessel F RuniaLawrence SteinmanRogier Q HintzenJoep KillesteinMarcel M VerbeekCharlotte E TeunissenBrigit A de JongPublished in: Journal of neuroinflammation (2017)
We have been able to identify and validate absence of miR-219 detection in CSF of MS patients compared to controls, suggesting that it may emerge as a candidate biomarker for MS diagnosis.